Aurora Cannabis Inc (ACB) Receives Consensus Rating of “Buy” from Analysts

Shares of Aurora Cannabis Inc (TSE:ACB) have received an average recommendation of “Buy” from the six research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is C$13.80.

Several research firms have issued reports on ACB. Bank of America set a C$15.00 target price on Aurora Cannabis and gave the company a “buy” rating in a research note on Wednesday. Cowen reiterated an “outperform” rating and issued a C$14.00 target price on shares of Aurora Cannabis in a research note on Tuesday, March 5th. Jefferies Financial Group reiterated a “buy” rating and issued a C$12.00 target price on shares of Aurora Cannabis in a research note on Monday, February 25th. Seaport Global Securities reiterated a “neutral” rating on shares of Aurora Cannabis in a research note on Thursday, February 21st. Finally, Eight Capital cut their target price on Aurora Cannabis from C$17.00 to C$15.00 in a research note on Wednesday, January 9th.

ACB traded up C$0.19 on Wednesday, hitting C$12.01. The company had a trading volume of 8,862,130 shares, compared to its average volume of 16,960,629. Aurora Cannabis has a 12-month low of C$5.29 and a 12-month high of C$16.24. The company has a debt-to-equity ratio of 8.08, a current ratio of 3.31 and a quick ratio of 1.89. The firm has a market capitalization of $11.73 billion and a PE ratio of -121.11.

Aurora Cannabis (TSE:ACB) last posted its earnings results on Monday, February 11th. The company reported C($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of C($0.06) by C$0.01. The company had revenue of C$54.18 million during the quarter, compared to analysts’ expectations of C$52.13 million. As a group, sell-side analysts expect that Aurora Cannabis will post 0.0299747682090031 EPS for the current year.

About Aurora Cannabis

Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis, and hemp production, derivatives, home cultivation, wholesale and retail distribution.

Featured Story: What is channel trading?

Analyst Recommendations for Aurora Cannabis (TSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with's FREE daily email newsletter.